Sartorius Stedim Biotech Q1 Profit Rises On Revenue Growth; Confirms FY26 Outlook

AI Briefing

• – Sartorius Stedim Biotech SA reports higher Q1 profit and revenue growth.
• – Maintains FY2026 outlook despite quarterly results.
• – CEO remains confident in guidance.